These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34682752)

  • 1. Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1022-1037. PubMed ID: 34962070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.
    Jo HS; Park JS; Sohn JW; Yoon JC; Sohn CW; Lee SH; Hong GR; Shin DG; Kim YJ; Jeong MH; Chae SC; Hur SH; Hong TJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi DH; Jang YS; Yoon JH; Chung WS; Seung KB; Park SJ
    Korean Circ J; 2011 Dec; 41(12):718-25. PubMed ID: 22259602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2
    Kwon SW; Park SD; Moon J; Oh PC; Jang HJ; Park HW; Kim TH; Lee K; Suh J; Kang W
    Korean Circ J; 2018 Nov; 48(11):989-999. PubMed ID: 30334385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents.
    Hsieh MJ; Chen CC; Lee CH; Wang CY; Chang SH; Chen DY; Yang CH; Tsai ML; Yeh JK; Ho MY; Hsieh IC
    Heart Vessels; 2019 Feb; 34(2):251-258. PubMed ID: 30159655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease.
    Wang C; Lang J; Zhang J; Hu Y; Han C; Xu R; Wu J; Liu C; Li W; Li T; Wei A; Qi W; Jin D; Cong H; Wang L
    Front Cardiovasc Med; 2022; 9():1033475. PubMed ID: 36505387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33478003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28214. PubMed ID: 34889307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
    Atherosclerosis; 2022 Mar; 344():60-70. PubMed ID: 34924173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
    de La Torre Hernandez JM; Gomez Hospital JA; Baz JA; Brugaletta S; Perez de Prado A; Linares JA; Lopez Palop R; Cid B; Garcia Camarero T; Diego A; Gutierrez H; Fernandez Diaz JA; Sanchis J; Alfonso F; Blanco R; Botas J; Navarro Cuartero J; Moreu J; Bosa F; Vegas JM; Elizaga J; Arrebola AL; Hernandez F; Salvatella N; Monteagudo M; Gomez Jaume A; Carrillo X; Martin Reyes R; Lozano F; Rumoroso JR; Andraka L; Dominguez AJ
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):580-588. PubMed ID: 29306670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26947. PubMed ID: 34397947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.